Retrospective application of a set of clinical diagnostic criteria for the diagnosis of multiple system atrophy

被引:35
作者
Litvan, I
Booth, V
Wenning, GK
Bartko, JJ
Goetz, CG
McKee, A
Jankovic, J
Jellinger, K
Lai, EC
Brandel, JP
Verny, M
Chaudhuri, KR
Pearce, RKB
Agid, Y
机构
[1] NINCDS, Neuroepidemiol Branch, Bethesda, MD 20892 USA
[2] NIMH, Div Epidemiol & Res Studies, Bethesda, MD 20892 USA
[3] Neurol Inst, London, England
[4] Rush Med Coll, Dept Neurol, Chicago, IL 60612 USA
[5] Massachusetts Gen Hosp, Dept Neuropathol, Boston, MA 02114 USA
[6] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA
[7] Lainz Hosp, Ludwig Boltzmann Inst Clin Neurobiol, A-1130 Vienna, Austria
[8] Federat Neurol, Paris, France
[9] INSERM U289, Paris, France
[10] Hop La Pitie Salpetriere, INSERM U360, Raymond Escourolle Neuropathol Lab, Paris, France
[11] Inst Psychiat, Dept Neurol, London SE5 8AF, England
[12] Neurol Inst, Parkinsons Dis Soc, Brain Tissue Bank, London, England
关键词
multiple system atrophy; clinical diagnosis; validity studies;
D O I
10.1007/s007020050050
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
We estimated the accuracy of a modified commonly used set of clinical diagnostic criteria for the diagnosis of multiple system atrophy (MSA) by retrospectively applying the criteria to the features recorded by six neurologists who had evaluated 105 autopsy-confirmed cases (16 MSA and 89 non-MSA disorders). Cases were abstracted from the records of the patients' first visit to an academic center: and were presented as clinical vignettes to six neurologists, each of whom recorded the main clinical features of the presented clinical vignette on a standardized form. Sensitivity and positive predictive values were chosen as validity outcome measures and were calculated by comparing the applied diagnostic criteria to the neuropathologic information. Of note, most MSA patients in this study (mainly those with Shy-Drager type) had not received levodopa therapy since the primary neurologists often had not perceived a need to administer this treatment. The validity of the retrospectively applied criteria for the diagnosis of possible MSA (sensitivity: median, 53%, range, 50-69%; positive predictive value: 30%, 28-39%) and probable MSA (sensitivity: 44%, 31-60%; positive predictive value: 68%, 54-80%) at the first visit was suboptimal. The best, still not perfect, accuracy for this set of diagnostic criteria was obtained when six out of eight features (sporadic adult onset, dysautonomia, parkinsonism, pyramidal signs, cerebellar signs, no levodopa response, no cognitive dysfunction, or no downward gaze supranuclear palsy) were present (median sensitivity, 59%; range, 50-75%; positive predictive value: 67%, 53-83%). This is the first study to validate criteria for the clinical diagnosis of MSA. Our data suggest that it is difficult to achieve an early and accurate clinical diagnosis of this disorder. The probability of correctly diagnosing MSA increases when at least six features of this modified set of criteria are present or when requiring the set for probable MSA.
引用
收藏
页码:217 / 227
页数:11
相关论文
共 32 条
[1]  
ADAMS RD, 1964, J NEUROPATH EXP NEUR, V23, P584
[2]   MULTIPLE SYSTEM ATROPHY PRESENTING AS PARKINSONISM - CLINICAL-FEATURES AND DIAGNOSTIC-CRITERIA [J].
ALBANESE, A ;
COLOSIMO, C ;
BENTIVOGLIO, AR ;
FENICI, R ;
MELILLO, G ;
COLOSIMO, C ;
TONALI, P .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1995, 59 (02) :144-151
[3]   DIFFERING PATTERNS OF STRIATAL F-18 DOPA UPTAKE IN PARKINSONS-DISEASE, MULTIPLE SYSTEM ATROPHY, AND PROGRESSIVE SUPRANUCLEAR PALSY [J].
BROOKS, DJ ;
IBANEZ, V ;
SAWLE, GV ;
QUINN, N ;
LEES, AJ ;
MATHIAS, CJ ;
BANNISTER, R ;
MARSDEN, CD ;
FRACKOWIAK, RSJ .
ANNALS OF NEUROLOGY, 1990, 28 (04) :547-555
[4]   STRIATAL OPIOID RECEPTOR-BINDING IN PARKINSONS-DISEASE, STRIATONIGRAL DEGENERATION AND STEELE-RICHARDSON-OLSZEWSKI SYNDROME - A [C-11] DIPRENORPHINE PET STUDY [J].
BURN, DJ ;
RINNE, JO ;
QUINN, NP ;
LEES, AJ ;
MARSDEN, CD ;
BROOKS, DJ .
BRAIN, 1995, 118 :951-958
[5]   SOME SPECIFIC CLINICAL-FEATURES DIFFERENTIATE MULTIPLE SYSTEM ATROPHY (STRIATONIGRAL VARIETY) FROM PARKINSONS-DISEASE [J].
COLOSIMO, C ;
ALBANES, A ;
HUGHES, AJ ;
DEBRUIN, VMS ;
LEES, AJ .
ARCHIVES OF NEUROLOGY, 1995, 52 (03) :294-298
[6]   DIFFERENTIATION OF MULTIPLE SYSTEM ATROPHY FROM IDIOPATHIC PARKINSONS-DISEASE USING PROTON MAGNETIC-RESONANCE SPECTROSCOPY [J].
DAVIE, CA ;
WENNING, GK ;
BARKER, GJ ;
TOFTS, PS ;
KENDALL, BE ;
QUINN, N ;
MCDONALD, WI ;
MARSDEN, CD ;
MILLER, DH .
ANNALS OF NEUROLOGY, 1995, 37 (02) :204-210
[7]  
DEJERINE J, 1990, NOUV ICONOGR SALPET, V13, P330
[8]  
Galen RS, 1975, NORMALITY PREDICTIVE
[9]   The relationship of multiple system atrophy to sporadic olivopontocerebellar atrophy and other forms of idiopathic late-onset cerebellar atrophy [J].
Gilman, S ;
Quinn, NP .
NEUROLOGY, 1996, 46 (05) :1197-1199
[10]   PATTERNS OF CEREBRAL GLUCOSE-METABOLISM DETECTED WITH POSITION EMISSION TOMOGRAPHY DIFFER IN MULTIPLE SYSTEM ATROPHY AND OLIVOPONTOCEREBELLAR ATROPHY [J].
GILMAN, S ;
KOEPPE, RA ;
JUNCK, L ;
KLUIN, KJ ;
LOHMAN, M ;
STLAURENT, RT .
ANNALS OF NEUROLOGY, 1994, 36 (02) :166-175